To address this issue, patients were defined as having Parkinson’s disease based on the disease code as well as the prescription of Parkinson’s disease drugs, including L-dopa, dopamine agonists and MAO-B inhibitors. The gene discussed is MAOB; the disease is Parkinson disease.